1. The role of Nav1.7 in human nociceptors: insights from human induced pluripotent stem cell-derived sensory neurons of erythromelalgia patients
- Author
-
Roman Goetzke, Herdit M. Schüler, Marc Rogers, Ellen Jørum, Angelika Lampert, Martin Hampl, Elisangela Bressan, Anthony M. Rush, Martin Zenke, Zacharias Kohl, Clara M. Kerth, Thi Kim Chi Le, Barbara Namer, Alec Foerster, Petra Hautvast, Martin Schmelz, Corinna Rösseler, Wolfgang Wagner, Kim Le Cann, Inge Petter Kleggetveit, Beate Winner, Jannis E. Meents, and Stephanie Sontag
- Subjects
Patch-Clamp Techniques ,Action potential ,Action Potentials ,Membrane Potentials ,0302 clinical medicine ,030202 anesthesiology ,Ganglia, Spinal ,pharmacology [Tetrodotoxin] ,pain ,Induced pluripotent stem cell ,Prepulse inhibition ,genetics [NAV1.7 Voltage-Gated Sodium Channel] ,NAV1.7 Voltage-Gated Sodium Channel ,Nociceptors ,Afterhyperpolarization ,cytology [Induced Pluripotent Stem Cells] ,Erythromelalgia ,metabolism [NAV1.7 Voltage-Gated Sodium Channel] ,iPS cells ,Neurology ,genetics [Pain] ,genetics [Erythromelalgia] ,Nociceptor ,sodium channel ,Research Paper ,physiology [Nociceptors] ,Sensory Receptor Cells ,Induced Pluripotent Stem Cells ,Pain ,Sensory system ,Tetrodotoxin ,physiopathology [Erythromelalgia] ,patch clamp ,03 medical and health sciences ,methods [Patch-Clamp Techniques] ,stem cells ,medicine ,Voltage-gated sodium channel ,metabolism [Sensory Receptor Cells] ,Humans ,ddc:610 ,business.industry ,drug effects [Action Potentials] ,cytology [Ganglia, Spinal] ,Sodium channel ,drug effects [Membrane Potentials] ,medicine.disease ,diagnosis [Pain] ,Electric Stimulation ,methods [Electric Stimulation] ,Anesthesiology and Pain Medicine ,nervous system ,Neurology (clinical) ,Inherited pain syndrome ,business ,Action potential firing ,Neuroscience ,Patch-clamp ,030217 neurology & neurosurgery - Abstract
Supplemental Digital Content is Available in the Text. Human sodium channel NaV1.7 in induced pluripotent stem cell–derived sensory neurons sets the action potential threshold but does not support subthreshold depolarizations., The chronic pain syndrome inherited erythromelalgia (IEM) is attributed to mutations in the voltage-gated sodium channel (NaV) 1.7. Still, recent studies targeting NaV1.7 in clinical trials have provided conflicting results. Here, we differentiated induced pluripotent stem cells from IEM patients with the NaV1.7/I848T mutation into sensory nociceptors. Action potentials in these IEM nociceptors displayed a decreased firing threshold, an enhanced upstroke, and afterhyperpolarization, all of which may explain the increased pain experienced by patients. Subsequently, we investigated the voltage dependence of the tetrodotoxin-sensitive NaV activation in these human sensory neurons using a specific prepulse voltage protocol. The IEM mutation induced a hyperpolarizing shift of NaV activation, which leads to activation of NaV1.7 at more negative potentials. Our results indicate that NaV1.7 is not active during subthreshold depolarizations, but that its activity defines the action potential threshold and contributes significantly to the action potential upstroke. Thus, our model system with induced pluripotent stem cell–derived sensory neurons provides a new rationale for NaV1.7 function and promises to be valuable as a translational tool to profile and develop more efficacious clinical analgesics.
- Published
- 2019